BGC20-1531, a novel, potent and selective prostanoid EP receptor antagonist: a putative new treatment for migraine headache.

Autor:	Maubach, K. A.1 karen.maubach@btgplc.com, Davis, R. J.2, Clark, D. E.3, Fenton, G.3, Lockey, P. M.3, Clark, K. L.4, Oxford, A. W.5, Hagan, R. M.1, Routledge, C.1, Coleman, R. A.5
Zdroj:	British Journal of Pharmacology. Jan2009, Vol. 156 Issue 2, p316-327. 12p. 1 Diagram, 8 Graphs.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu